Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma.
Saved in:
| Title: | Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma. |
|---|---|
| Authors: | Shin J; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Parker MFL; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Zhu I; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Alanizi A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Rodriguez CI; Department of Pathology, University of California, San Francisco, San Francisco, California., Liu R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Watchmaker PB; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California., Kalita M; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Blecha J; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Luu J; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Wright B; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama., Lapi SE; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, California., Okada H; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, California., Tlsty TD; Department of Pathology, University of California, San Francisco, San Francisco, California; david.m.wilson@ucsf.edu kole.roybal@ucsf.edu thea.tlsty@ucsf.edu., Roybal KT; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California; david.m.wilson@ucsf.edu kole.roybal@ucsf.edu thea.tlsty@ucsf.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, California.; Chan Zuckerberg Biohub, San Francisco, California.; Gladstone UCSF Institute for Genetic Immunology, San Francisco, California; and.; UCSF Cell Design Institute, San Francisco, California., Wilson DM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California; david.m.wilson@ucsf.edu kole.roybal@ucsf.edu thea.tlsty@ucsf.edu. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Jan; Vol. 64 (1), pp. 137-144. Date of Electronic Publication: 2022 Aug 18. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
